English
SpanishTrusted Resources: News & Meetings
Latest announcements and gatherings
TEPEZZA Has Resumed Production – FAQ
Horizon Therapeutics, the developer of TEPEZZA, prepared this document to address questions from the Thyroid Eye Disease (TED) community about the resumed production of TEPEZZA, a medicine for TED. Patients can now schedule their infusions. Read on for information about how to schedule infusions, insurance considerations and answers to other frequently asked questions.
Note: If you choose to share or post these FAQs, please share the full document and not select pieces of it, in order to comply with regulatory guidelines.
Questions about TEPEZZA? Talk to Horizon Patient Services.
Call 1-833-469-8331, Mon-Fri, 8 AM – 8 PM EST.
Horizon Patient Services does not provide individual patient care or medical advice.
myBinderRelated Content
-
Horizon Therapeutics plc Increases Peak U.S. Annual Net Sales Expectations for Key Growth DriversHorizon Therapeutics plc announced today...
-
Clinical Study Data Highlighting the Impact of Teprotumumab in Patients With Active Thyroid Eye Disease to Be Presen...Horizon Therapeutics plc today announced...
-
Teprotumumab, an Insulin-Like Growth Factor-1 Receptor Antagonist Antibody, in the Treatment of Active Thyroid eye D...Thyroid eye disease is a disabling autoi...
-
Meeting of Dermatologic and Ophthalmic Drugs Advisory Committee AnnouncementThe committee will discuss biologics lic...
-
Integrated Clinical Trial Analyses Further Substantiate that Teprotumumab Significantly Improves Debilitating Effect...Horizon Therapeutics plc today announced...
-
TEPEZZA Short-Term Supply Disruption FAQHorizon Therapeutics plc announced that ...
-
Thyroid Eye Disease Drug Meets Primary Endpoint for Proptosis ReductionTop-line results from the OPTIC trial sh...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Brought to you by
Supported through an independent
educational grant by
